Tomaso Piaggio

Tomaso Piaggio is an experienced professional in market access and health technology assessment, currently serving as the Head of International Market Access for the Southern Cluster (Italy, Spain, Portugal) and Japan at Alnylam Pharmaceuticals since August 2022. Prior to this role, Tomaso held various positions at Biogen, including Director of Value, Access & Government Affairs for the Neuromuscular Disorders Intercontinental Region and leadership roles in Alzheimer’s Disease and Spinal Muscular Atrophy access initiatives. Previous experience includes senior market access management at Baxter International Inc. and Novo Nordisk, as well as roles at Sanofi and Eli Lilly and Company. Tomaso began the career in international sales and marketing and has a robust educational background, including an MBA from the University of Warwick, an MSc from the University of York, and a PharmD from Università degli Studi di Genova.